- Determining predictors of response to exenatide in type 2 diabetesSarah L Anderson
School of Pharmacy, University of Colorado, 12850 E Montview Blvd, Aurora, CO 80045, USA
J Am Pharm Assoc (2003) 52:466-71. 2012..To determine predictors of glycemic response to exenatide and to assess change in glycosylated hemoglobin (A1C) and whether a correlation exists between weight loss and glycemic response...
- Dapagliflozin for the treatment of type 2 diabetesSarah L Anderson
University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO, USA
Ann Pharmacother 46:590-8. 2012....
- Association of pancreatitis with glucagon-like peptide-1 agonist useSarah L Anderson
School of Pharmacy, University of Colorado Denver, Aurora, CO 80045, USA
Ann Pharmacother 44:904-9. 2010..To review the possible association between glucagon-like peptide-1 (GLP-1) agonist use and pancreatitis in patients with type 2 diabetes mellitus...